1f4d: Difference between revisions
No edit summary |
No edit summary |
||
Line 4: | Line 4: | ||
|PDB= 1f4d |SIZE=350|CAPTION= <scene name='initialview01'>1f4d</scene>, resolution 2.15Å | |PDB= 1f4d |SIZE=350|CAPTION= <scene name='initialview01'>1f4d</scene>, resolution 2.15Å | ||
|SITE= | |SITE= | ||
|LIGAND= <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene>, <scene name='pdbligand=TP2:N-[TOSYL-D-PROLINYL]AMINO-ETHANETHIOL'>TP2</scene> | |LIGAND= <scene name='pdbligand=CXM:N-CARBOXYMETHIONINE'>CXM</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene>, <scene name='pdbligand=TP2:N-[TOSYL-D-PROLINYL]AMINO-ETHANETHIOL'>TP2</scene> | ||
|ACTIVITY= <span class='plainlinks'>[http://en.wikipedia.org/wiki/Thymidylate_synthase Thymidylate synthase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.1.1.45 2.1.1.45] </span> | |||
|GENE= | |GENE= | ||
|DOMAIN= | |||
|RELATEDENTRY=[[1f4b|1F4B]], [[1f4c|1F4C]], [[1f4e|1F4E]], [[1f4f|1F4F]], [[1f4g|1F4G]] | |||
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1f4d FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1f4d OCA], [http://www.ebi.ac.uk/pdbsum/1f4d PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=1f4d RCSB]</span> | |||
}} | }} | ||
Line 30: | Line 33: | ||
[[Category: Stroud, R M.]] | [[Category: Stroud, R M.]] | ||
[[Category: Wells, J A.]] | [[Category: Wells, J A.]] | ||
[[Category: crystal structure of e. coli thymidylate synthase c146]] | [[Category: crystal structure of e. coli thymidylate synthase c146]] | ||
[[Category: l143c covalently modified at c143 with n-[tosyl-d-prolinyl]amino-ethanethiol]] | [[Category: l143c covalently modified at c143 with n-[tosyl-d-prolinyl]amino-ethanethiol]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Mar 30 20:15:35 2008'' |
Revision as of 20:15, 30 March 2008
| |||||||
, resolution 2.15Å | |||||||
---|---|---|---|---|---|---|---|
Ligands: | , , , | ||||||
Activity: | Thymidylate synthase, with EC number 2.1.1.45 | ||||||
Related: | 1F4B, 1F4C, 1F4E, 1F4F, 1F4G
| ||||||
Resources: | FirstGlance, OCA, PDBsum, RCSB | ||||||
Coordinates: | save as pdb, mmCIF, xml |
CRYSTAL STRUCTURE OF E. COLI THYMIDYLATE SYNTHASE C146S, L143C COVALENTLY MODIFIED AT C143 WITH N-[TOSYL-D-PROLINYL]AMINO-ETHANETHIOL
OverviewOverview
We report a strategy (called "tethering") to discover low molecular weight ligands ( approximately 250 Da) that bind weakly to targeted sites on proteins through an intermediary disulfide tether. A native or engineered cysteine in a protein is allowed to react reversibly with a small library of disulfide-containing molecules ( approximately 1,200 compounds) at concentrations typically used in drug screening (10 to 200 microM). The cysteine-captured ligands, which are readily identified by MS, are among the most stable complexes, even though in the absence of the covalent tether the ligands may bind very weakly. This method was applied to generate a potent inhibitor for thymidylate synthase, an essential enzyme in pyrimidine metabolism with therapeutic applications in cancer and infectious diseases. The affinity of the untethered ligand (K(i) approximately 1 mM) was improved 3,000-fold by synthesis of a small set of analogs with the aid of crystallographic structures of the tethered complex. Such site-directed ligand discovery allows one to nucleate drug design from a spatially targeted lead fragment.
About this StructureAbout this Structure
1F4D is a Single protein structure of sequence from Escherichia coli. Full crystallographic information is available from OCA.
ReferenceReference
Site-directed ligand discovery., Erlanson DA, Braisted AC, Raphael DR, Randal M, Stroud RM, Gordon EM, Wells JA, Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9367-72. PMID:10944209 [[Category: l143c covalently modified at c143 with n-[tosyl-d-prolinyl]amino-ethanethiol]]
Page seeded by OCA on Sun Mar 30 20:15:35 2008